hydrogen
result
linked
ddy
rate
versu
speculated
medicine
tissue
formic
test
chlorosuccinimide
research
2014
68ga
coefficient
blocking
biodistribution
protein
obtain
CP
treat
evaluate
flow
strategy
not
injected
phosphorylation
counter
radiopharmaceutical
akira
targeted
introduced
normal
MS
structure
studie
lead
buffer
pharmaceutical
benzyl
application
tin
sensitivity
site
synthesi
relatively
radiotherapy
incorporated
125I
HPLC
365
15O
tool
carrier
phase
𝑟𝑎𝑑𝑖𝑜𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦
TEA
initiative
mice
MCF7
okayama
kinase
sacrifice
synthesized
rac
957
iodine1
partition
non
ing
receptor
shiba4
propertie
TFA
imaging
camera
incubation
uptake
effendi1
positron
afford
ATP
used
purity
therapy
synthesize
molecule
cell
radioisotope
development
life
compared
966
mode
it
reference
1000
half
organic
dose
kid
however
evaluation
into
13N
124I
2011
radiolabeling
overnight
quinoline
but
ID
room
dentistry
asses
ogawa1
loc
BINAP
meaningful
wherein
stability
kazuma
309
modification
SPECT
suppl
boc2o
basic
3graduate
nurmaya
containing
water
US
under
school
76br
111in
luc
odani1
iodo
IIQ
binding
time
peroxide
piperidine
673
meoh
needed
more
benzoyl
single
reactive
palladium
859
expressed
mishiro2
bearing
accumulation
log
PET
yield
wa
tungstate
acetate
NCS
inhibit
boronic
column
same
without
emission
potassium
absorbance
18F
acid
one
iododestannylation
150
123I
variety
2008
chromatogram
hexabutyldistannane
cancer
125
promising
radioanal
centre
4advanced
1215
only
dipalladium
science
bi
primary
pocl3
oncology
2onco
II
emitting
kazuhiro
PDGFRα
IIQP
reaction
developing
well
radioiodinated
useful
element
rin
nte
1221
long
chemical
temperature
radiotracer
concept
blogspot
bromide
1pharmaceutical
EC
2institute
cesium
inoculation
takarada3
http
chem
phosphate
halogenation
𝑜𝑟𝑔𝑎𝑛𝑖𝑐
UV
radionuclide
measured
kanazawa
106
sodium
PBS
mscl
statu
indirectly
11C
because
control
precursor
study
also
stable
method
451
x105
clearance
tumor
1cancer
respectively
pharm
C6H5
after
tomography
yoji
nude
added
high
diagnostic
initial
way
𝑳𝒐𝒈
tyrosine
phenyl
layer
ATE
5C18
kitamura4
inhibitor
electron
yamada3
131I
PDGFR
vitro
hcl
target
iodine
mobile
DIPHOS
photon
amine
value
other
potent
biological
𝑤𝑎𝑡𝑒𝑟
octanol
puritie
easily
384
mediumtime
new
drug
introduction
may
373
2005
auger
min
mutation
benzimidazole
mouse
capture
variou
chloride
derivative
radiolabeled
nai
radiochemical
99mtc
anhydrate
university
using
IB
67ga
frontier
computed
2016
TKI
block
dibenzylideneacetone
bxpc3
reflux
carbonate
attractive
acetic
PDGFRβ
nucl
competitively
rev
compound
general
might
𝑙𝑜𝑔
tri
re
group
trifluoromethanesulfonimide
115
preparation
conclusion
dihydrate
act
daisuke
𝑙𝑎𝑦𝑒𝑟
selective
appropriate
formamidine
agent
decay
radioactivity
IQP
IC50
takeshi
100
vivo
kenji
isotope
889
ther
condition
could